Format

Send to

Choose Destination
See comment in PubMed Commons below
Pain. 2014 Jan;155(1):14-21. doi: 10.1016/j.pain.2013.08.013. Epub 2013 Aug 19.

Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain.

Author information

1
Pain Research and Nuffield Division of Anaesthetics, Nuffield Department of Neurosciences, University of Oxford, The Churchill, Oxford, UK. Electronic address: andrew.moore@ndcn.ox.ac.uk.
2
Pain Research and Nuffield Division of Anaesthetics, Nuffield Department of Neurosciences, University of Oxford, The Churchill, Oxford, UK.
3
Institute of Occupational, Social and Environmental Medicine, University Medical Center Göttingen, Göttingen, Germany.
4
Spreadsheet Factory, Stratfield Road, Oxford, UK.

Abstract

A Cochrane review of ibuprofen in acute pain suggested that rapidly absorbed formulations of salts, or features to speed absorption, provided better analgesia than standard ibuprofen as the free acid. We examined several lines of evidence to investigate what benefit derived from fast-acting formulations. A systematic review of the kinetics of oral ibuprofen (30 studies, 1015 subjects) showed that median maximum plasma concentrations of fast-acting formulations occurred before 50 min (29-35 min for arginine, lysine, and sodium salts) compared with 90 min for standard formulations. An updated analysis of clinical trials (over 10,000 patients) showed that fast-acting formulations produced significantly better analgesia over 6h and fewer remedications than standard formulations in both indirect and direct comparisons. In dental studies, 200-mg fast-acting ibuprofen (number needed to treat 2.1; 95% confidence interval 1.9-2.4) was as effective as 400 mg standard ibuprofen (number needed to treat 2.4; 95% confidence interval 2.2-2.5), with faster onset of analgesia. Individual patient data analysis in dental pain demonstrated a strong correlation between more rapid reduction of pain intensity over 0-60 min and better pain relief over 0-6h. Rapid initial reduction of pain intensity was also linked with reduced need for remedication. Fast-acting formulations of ibuprofen demonstrated more rapid absorption, faster initial pain reduction, good overall analgesia in more patients at the same dose, and probably longer-lasting analgesia, but with no higher rate of patients reporting adverse events. Achieving a better analgesic effect with fast-acting nonsteroidal anti-inflammatory drug formulations has important implications for safety. Formulation chemistry is of potential importance for analgesics.

KEYWORDS:

Acute pain; Fast-acting; Formulation; Ibuprofen; NSAID

PMID:
23969325
DOI:
10.1016/j.pain.2013.08.013
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center